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Abstract Although the ceramide components of both glyco- 
sphingolipids (GSLs) and sphingomyelin (SM) in HL-60 cells 
were identical, the molecular species of the ceramides preferen- 
tially used in biosynthesis were quite different in GSLs and SM. 
When HL-60 cells were stimulated to differentiate into macro- 
phage-like cells by phorbol ester after their sphingolipids had been 
metabolically labeled with L-13-14C]serine to saturation point, 
marked changes in the radioactivities of the ceramide residues 
were observed in GSLs, showing the activation of a biosynthetic 
pathway of ganglioside GM3. No significant changes were, how- 
ever, observed in the ceramide residues of SM. These results 
indicate that it is necessary to consider the overall metabolism of 
ceramides, including their origin, when investigating the functions 
of ceramides in signal transduction systems. 
tion of the possible role of GSLs, even though both GSLs and 
SM contain ceramide. To clarify- the physiological significance 
of sphingolipids, it is important o study the overall cellular 
stimulus-induced metabolism of GSLs and SM. However, only 
a few attempts have so far been made to investigate the relation- 
ship between their metabolic pathways [4,5]. 
In the present study, we first established a simple method 
which enabled simultaneous analysis of GSLs and SM in the 
total lipid fraction of cultured cells by two-dimensional 
HPTLC. Early changes in sphingolipid metabolism, including 
GSLs and SM, during the macrophage-like differentiation of 
HL-60 cells [6,7] were then analyzed to estimate the physiolog- 
ical significance of sphingolipids in the differentiation process. 
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1. Introduction 
GSLs, especially certain gangliosides, have recently been re- 
ported to participate in essential biological processes uch as 
cell-cell interactions, cell differentiation and signal transduc- 
tion [1]. Sphingosine derivatives, including ceramides, which 
are considered as breakdown products of GSLs and SM, have 
also been demonstrated to modulate a variety of biological 
events following initial reports of their effects on protein kinase 
C [1,2]. Subsequent studies on the generation of sphingosine 
derivatives led to the hypothesis that SM might be degraded 
and generate ceramides in response to various cellular stimuli, 
and may thus be involved in a novel signal transduction system 
[3]. However, this hypothesis does not include any considera- 
2. Materials and methods 
2.1. Materials 
1.-[3 14C]Serine was purchased from Amersham, UK. CMP- 
[3H]NeuAc and [4~4C]cholesterol were purchased from NEN, Boston, 
MA. TPA was obtained from Calbiochem, La Jolla, CA. PC, PE, PS, 
SM, PGIy and CL were purchased from Avanti Polar Lipids, Alabaster, 
AL. PI, CH and triolein were obtained from serdary Research Labora- 
tories, Ontario, Canada. CMH, CDH, PG and GM3 were purchased 
from Iatron, Tokyo, Japan. Cer and Sp were obtained from Sigma, St. 
Louis, MO; SplP and HL-60 cells were kindly donated by Dr. Sen- 
itiroh Hakomori (University of Washington, Seattle) and Dr. S.J. Col- 
lins (University of Washington, Seattle), respectively. Mouse melanoma 
cell line B16 was obtained from American Type Culture Collection. All 
other reagents were of analytical or HPLC grade. 
2.2. Cell culture 
HL-60 cells were grown in RPMI 1640 containing 10% fetal calf 
serum, 100 IU/ml penicillin, and 100/zg/ml streptomycin. I  the meta- 
bolic labeling study, the cells were cultured in the presence of 300 
nCi/ml 1"-[3-14C]serine. Monocytic differentiation was induced by TPA, 
and was evaluated morphologically and cytochemically asdescribed 
previously [8,9]. B16 cells were cultured under the same conditions as 
those for HL-60 cells. 
*Corresponding author. Fax: (81) (426) 85-1345. 
Abbreviations: CDH, lactosylceramide; Cer, ceramide; CH, cholesterol; 
CL, cardiolipin; CMH, glucosylceramide; FAB-MS, fast atom bom- 
bardment mass pectrometry; GLC, gas-liquid chromatography; GM3, 
II3NeuAc-lactosylceramide; GSL, glycosphingolipid; HPLC, high-per- 
formance liquid chromatography; HPTLC, high-performance thin- 
layer chromatography; NeuAc, N-acetylneuraminic a id; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PG, paraglo- 
boside; PGly, phosphatidylglycerol; PI, phosphatidylinositol; PS, 
phosphatidylserine; RP, reversed-phase; SM, sphingomyelin; Sp, sphin- 
gosine; SplP, sphingosine-l-phosphate; TG, triacylglycerol; TPA, 12- 
O-tetradecanoylphorbol 13-acetate. 
2.3. Extraction of total lipids 
The cells were washed twice with phosphate-buffered saline. Then 
total ipid was extracted sequentially with a lower phase of isopropanol/ 
n-hexane/water 55 :25:20 (v/v/v), chloroform/methanol 1 : 2 (v/v) and 
chloroform/methanol 2:1 (v/v) [10]. In the radiolabeling study, [4~ 
14C]cholesterol was used as an internal standard. 
2.4. Two-dimensional thin-layer chromatography 
The total lipid extract from each cell preparation was spotted in the 
lower left-hand corner of a HPTLC plate (Merck #5641, 10 cm x 10 
cm). The first chromatographic run was performed with chloroform/ 
methanol/formic a id/water 65:25:8.9:1.1 (v/v/v/v) [11]. The second 
run was performed with chloroform/methanol/4.4 N ammonia 
50:40:10 (v/v/v) in rotating 90 ° from the original direction. Then the 
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third run was performed with diethylether in a direction opposite to 
that of the second run to separate ceramides from other neutral lipids. 
The plate was sprayed by HzSO 4 and the spots were visualized by 
heating. Each spot was identified by comparison with authentic stan- 
dards. The radioactivity of each spot was determined using a BAS 2000 
imaging analyzer (Fuji Film, Tokyo, Japan). 
2.5 Synthesis of[3H-NeuAc]GM3 
[3H-NeuAc]GM3 was synthesized enzymatically as described previ- 
ously [12], with a lysate of B16 cells as an enzyme source [13] and both 
CDH and CMP-[3H]NeuAc as substrates. 
2.6 Analysis of the molecular species of CMH, CDH and SM 
After hydrolysis of the glycerolipids with methanolic sodium hydrox- 
ide [14] and dialysis against water overnight, the sphingolipids were 
recovered from a silica gel column using a stepwise gradient of metha- 
nol in chloroform [15]. They were then applied to a silica gel HPLC 
column (Iatrobeads 6RSP-8010, 0.46 x 25 cm, Iatron, Tokyo, Japan) 
with isopropanolln-hexanelwater 35: 64:1 (v/v/v). CMH and CDH 
were eluted using a linear gradient of isopropanol/n-hexane/water 
55:44:1 (v/v/v) [16]. SM was purified by sequential HPLC from the 
total lipid fraction. First, silica gel HPLC was performed in iso- 
propanolln-hexanelwater 70:20:10 (v/v/v), and PC and SM were iso- 
cratically eluted and found to overlap [17]. Then SM was isolated on 
the same column using acetonitrile/methanol/water 70:20:10 (v/v/v) 
[18]. 
CMH and CDH were separated into molecular species using a RP- 
HPLC column (Senshu Pack, PEGASIL ODS, 0.46 x 15 cm) in metha- 
nol at 40°C [19]. SM was separated in methanol containing 0.1% (v/v) 
triethylamine. The molecular mass of the sphingolipids contained in 
each fraction was analyzed by negative- or positive-ion FAB-MS with 
a JEOL JMS-HX110 mass spectrometer with triethanolamine [20] as 
the matrix. Their fatty acid residues were analyzed by GLC as methyl 
ester derivatives [21] on a capillary column of cross-linked methylsili- 
cone [22]. The correlation between the upper or lower spot and each 
molecular species was estimated by TLC. 
3. Results 
3.1. Separation of ilL-60 cell total lipids by two-dimensional 
TLC 
Fig. 1 shows the separation pattern of HL-60 cell total lipids 
by HPTLC.  Phospholipids (PC, PE, PS, PI, SM), major neutral 
GSLs (CMH, CDH, PG), and GM3 were well separated as 
distinct spots. Most of the GSLs and SM showed doublet spots, 
each consisting of an upper spot and a lower one. Gangliosides 
with longer sugar chains were separated in the second run, 
although they were developed closely to each other. Major 
neutral ipids (CH, TG) were developed in the upper right-hand 
corner of the plate after the second run and separated in the 
third run as slightly large vague spots. When [3H-NeuAc]GM3 
was developed using the present solvent system, no detectable 
degradation of GM3 was observed. Intermediates ofbiosynthe- 
sis and/or breakdown products of GSLs and SM, such as cer- 
amide, sphingosine and sphingosine-l-phosphate were not de- 
tected by chemical-level analysis of HL-60 total ipids. 
3.2. Changes in sphingolipids of ilL-60 cells during monocytic 
differentiation i duced by TPA 
HL-60 cells were cultured in the presence of  L-[3-14C]serine. 
The radioactivity incorporated into the sphingolipid fraction of 
the cultured cells was only 0.3% of the added count. The incor- 
poration of the radioactivity into each sphingolipid almost 
reached a plateau after 4 days of culture. All GSLs incorpo- 
rated a larger amount of radioactivity into the upper spot of 
the doublet. In SM, the reverse was the case. 
HL-60 cells differentiated to macrophage-like c lls morpho- 
t- 
1 st 
Fig. 1. Two-dimensional thin-layer chromatogram of total ipids from HL-60 cells. Total lipids were applied to the lower left-hand corner of a HPTLC 
plate. The first chromatographic run was performed with chloroform/methanol/formic ac d/water 65:25:8.9:1.1 (v/v/v/v). Then the plate was 
developed with chloroform/methanol/4.4 N ammonia 50:40:10 (v/v/v) for the second imension. The third run was performed with diethylether in 
the opposite direction to the second run. The plate was sprayed with H2SO 4 and the spots was visualized by heating. 
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Fig. 2. Changes in radioactivities of sphingolipids in HL-60 cells induced to differentiate with 16 pM TPA. HL-60 cells metabolically abeled with 
I~-[3J4C]serine atequilibrium level were induced to differentiate omacrophage-like cells with TPA (e,=) or in a control culture (©,D). The radioactivity 
of each spot was analyzed by a BAS 2000 imaging analyzer, o,e, upper spot; [],m, lower spot. A, SM; B, CMH; C, CDH; D, GM3. 
logically and cytochemically with TPA in a dose-dependent 
manner, and the differentiation reached a plateau at 16 nM, as 
described previously [7]. No significant cell damage or toxicity 
was observed even at 1.6 ~tM TPA. When the cells were stimu- 
lated with 16 nM TPA, transient increases of CMH,  CDH, 
GM3 [23] and SM [24] were observed simultaneously. On the 
other hand, when the cells were stimulated with 1.6/.tM TPA, 
CMH,  CDH and GM3 increased (Fig. 2). However, SM did not 
change significantly. The radioactivity of the lower spot of SM 
and the upper spots of GSLs maintained a larger count than 
their respective counterparts during these changes. 
3.3 Molecular species of  the HL-60 sphingolipids 
CMH,  CDH and SM were separated as three major peaks 
by RP-HPLC.  The first peak of CMH gave a pseudo-molecular 
ion ([M-H]-) at m/z 698 by negative-ion FAB-MS and was 
shown to contain C16:0 fatty acid by GLC, indicating that this 
peak contained sphingenine (dl 8: 1) as the sphingoid base. The 
second peak of CMH was analyzed in the same way and found 
to be composed of two molecular species, d18:1-C22:0 (m/z 
782) and d18: 1-C24:1 (m/z 808). The third peak was d18: 1- 
C16:0 (m/z 810). The first peak, corresponding to the 
lower spot of CMH,  was developed on a TLC plate, as were 
the second and third peaks, upper spot (Table 1). The first, 
second and third peaks of CDH gave pseudo-molecular ions 
([M-HI-) at m/z 860, 944 plus 970 and 972 by negative-ion 
FAB-MS and were shown by GLC to contain C16:0, C22:0 
plus C24:1 and C24:0 fatty acids, respectively. In the case of 
SM, three peaks gave pseudo-molecular ions ([M+H] +) at m/z 
703, 787 plus 813 and 815 by positive-ion FAB-MS and were 
shown by GLC to contain C 16: 0, C22: 0 plus C24: 1 and C24: 0 
fatty acids, respectively. Both CDH and SM were found to 
contain sphingenine (d18: 1) as the sphingoid base. The behav- 
ior of the peaks of CDH or SM on TLC were analogous to 
those of CMH.  These data indicated that the ceramides of the 
upper spots of CMH,  CDH and SM were composed mainly of 
dl 8 : 1 sphingenine and C24: 0, C22: 0 and C24: 1 fatty acids, 
whereas the lower ones were composed of d18: l  sphingenine 
and C16:0 fatty acid. 
Table 1 
Molecular species of CMH, CDH and SM in HL-60 cells. 
The molecular species of each of the lipids were isolated by RP-HPLC 
as described in section 2. Each was analyzed by TLC, FAB-MS and 
GLC. 
Sphingolipids Peaks on Spots on Molecular species m[z a 
HPLC TLC of ceramides 
CMH first lower d 18 : 1-C 16: 0 698 b 
second upper dl 8 : 1-C22 : 0 782 b 
d18:1-C24: 1 808 b 
CDH third upper d 18 : 1-C24: 0 810 u 
first lower d18 : 1-C16:0 860 b 
second upper d 18 : 1-C22: 0 944 b 
d18 : 1-C24 : 1 970 b 
SM third upper d l 8 : 1-C24 : 0 972 b 
first lower d18 : 1-C16:0 703 c 
second upper d18 : 1-C22:0 787 c 
d18: 1-C24:1 813 c 
third upper d 18 : 1-C24: 0 815 ~ 
a Pseudo-molecular ion. 
b [M - H]- by negative-ion FAB-MS. 
~[M + H] + by positive-ion FAB-MS. 
480 
4. Discussion 
In the present study, we established a simple method for 
simultaneous analysis of GSLs and SM from the total lipid 
fraction of cultured cells by two-dimensional HPTLC. Al- 
though gangliosides contain acid-labile ketoside bonds [25], the 
use of an acidic solvent was necessary to separate major GSLs 
including angliosides, phospholipids and neutral lipids. How- 
ever, no detectable degradation of [3H-NeuAc]GM3 was ob- 
served, indicating that the ketoside bonds of gangliosides were 
sufficiently stable during development. 
Most of the GSLs and SM of HL-60 cells showed doublet 
spots. The molecular species analysis revealed that the cer- 
amides of the upper spots of both GSLs and SM were com- 
posed mainly of d18: l  sphingenine and C24:0, C22:0 and 
C24:1 fatty acids whereas the lower ones were com- 
posed of d18:1 sphingenine and C16:0 fatty acid. The upper 
spot of each GSL contained higher adioactivity than the lower 
one. In contrast, SM contained higher adioactivity in the lower 
spot. These relationships were also maintained uring the met- 
abolic changes in sphingolipids during HL-60 cell differentia- 
tion induced by TPA. These results indicate that the molecular 
species of ceramides which are used preferentially for biosyn- 
thesis differ between GSLs and SM, although both GSLs and 
SM are composed of the same molecular species of ceramides. 
The biological activities of ceramide have been assessed by 
utilization of synthetic analogues such as N-acetyl-sphingosine 
(C2-ceramide) toovercome the problem of aqueous insolubility 
of the natural compound [26]. In addition, C2-ceramide has 
been considered to substitute for ceramide derived from SM. 
However, our results strongly suggest that further studies 
should be performed to determine which molecular species of 
ceramide possess biological activities, in order to elucidate the 
overall stimulus-induced sphingolipid metabolism through 
which signals appear to be flowing. 
The radioactivities of both spots of GSL doublets changed 
in response to 1.6 ¢tM TPA, although the radioactivities of the 
SM doublet did not change. These r sults uggest that not only 
ceramide pools but also their metabolic regulation of ceramide 
in GSLs differ from those of SM, contrary to other investiga- 
tors who have speculated recently that the metabolic pathways 
of GSLs and SM interdependent [24] and that stimulation of 
ganglioside GM3 biosynthesis might be closely associated with 
macrophage-like c ll differentiation of HL-60 cells, the 'sphin- 
gomyelin cycle' possibly being unnecessary for this event. 
Most studies which have shown alterations of GSL profiles 
have focused only on the hydrophilic moiety. The present data 
support the consideration that further study should be per- 
formed taking into account not only the hydrophilic moiety but 
also the hydrophobic moiety in order to elucidate the precise 
mechanisms which regulate the metabolic pathways of GSLs 
and SM during cell differentiation. The present system should 
prove useful for such a study. 
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